CASP2 and cancer: To further investigate this, we profiled a panel of 60 different human cancer cell lines (NCI-60) by immunoblotting and found that 22 of them expressed RAIDD and caspase-2 at a level equal to or greater than that in HeLa cells (Fig. S1A).